Analyst firms · Raymond James · NEO
Raymond James NEO price target and rating history
NeoGenomics Inc. (NEO) · Health Care
Raymond James rates NeoGenomics Inc. (NEO) Mkt Perform with a $24 price target, as of its latest action on May 16, 2023. It has published 4 rating actions on NEO since October 2021, including 2 upgrades and 1 downgrade.
- Current rating
- Mkt Perform
- Price target
- $24
- Median target, all firms
- Too few
- Actions on NEO
- 4
Raymond James price target on NEO
Every Raymond James rating on NEO
- May 16, 2023
- Feb 24, 2022
- Oct 14, 2021
- Oct 14, 2021
How other firms rate NEO
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BTIG | Buy | $28 | Oct 6, 2026 |
| Leerink Partners | Outperform | $25 | Apr 29, 2026 |
Questions about Raymond James and NEO
- What is Raymond James's price target for NEO?
- Raymond James's latest stated price target for NeoGenomics Inc. (NEO) is $24, from its action on Feb 24, 2022.
- What is Raymond James's rating on NEO?
- Raymond James rates NEO Mkt Perform, a neutral rating, as of May 16, 2023.
- When did Raymond James last change its view on NEO?
- On May 16, 2023, Raymond James downgrades to Mkt Perform from Outperform.
More NEO rating histories
All Raymond James ratingsNEO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.